Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin

Bruce B Redmon, Howard C. Towle, Paul Robertson

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

We observed in the HIT cell, a clonal insulin-secreting cell line, that epinephrine and somatostatin lower insulin mRNA levels and intracellular insulin content in addition to the well-recognized effect of these hormones to inhibit insulin secretion. To determine whether these inhibitory hormones might regulate insulin synthesis at the level of insulin gene transcription, we studied HIT cell expression of a human insulin-chloramphenicol acetyl transferase (CAT) reporter gene in the presence of glucose, epinephrine, and somatostatin. HIT cell expression of this human insulin-CAT reporter gene was responsive to glucose in a concentration-dependent manner, increasing threefold as the glucose concentration increased from 0.4 to 11 mM. Epinephrine significantly inhibited insulin-CAT reporter gene expression (61 ± 5% of control), an effect mediated specifically by the human insulin gene promoter/enhancer sequence. Somatostatin significantly inhibited expression of the human insulin-CAT reporter gene (65 ± 4% of control) and, to a lesser extent, expression of a control reporter gene, pRSVCAT (78 ± 4% of control). Thus, somatostatin may inhibit insulin gene transcription by insulin gene- specific effects as well as more general effects on gene expression. Both epinephrine and somatostatin inhibited expression of the human insulin-CAT reporter gene in a concentration-dependent manner that paralleled inhibition of insulin secretion. These studies indicate that epinephrine and somatostatin lower HIT cell insulin mRNA levels in part by inhibiting insulin gene transcription. Thus, hormonal inhibition of insulin secretion may be coupled with inhibition of insulin synthesis, thereby allowing the β-cell to match insulin supply to secretory demand.

Original languageEnglish (US)
Pages (from-to)546-551
Number of pages6
JournalDiabetes
Volume43
Issue number4
DOIs
StatePublished - Jan 1 1994

Fingerprint

Somatostatin
Epinephrine
Insulin
Glucose
Genes
Reporter Genes
Chloramphenicol
Transferases
Hormones
Gene Expression
Messenger RNA
Insulin-Secreting Cells
acetylinsulin

Cite this

Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin. / Redmon, Bruce B; Towle, Howard C.; Robertson, Paul.

In: Diabetes, Vol. 43, No. 4, 01.01.1994, p. 546-551.

Research output: Contribution to journalArticle

Redmon, Bruce B ; Towle, Howard C. ; Robertson, Paul. / Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin. In: Diabetes. 1994 ; Vol. 43, No. 4. pp. 546-551.
@article{a20a7d0512c84c37a162bfeb1b786afc,
title = "Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin",
abstract = "We observed in the HIT cell, a clonal insulin-secreting cell line, that epinephrine and somatostatin lower insulin mRNA levels and intracellular insulin content in addition to the well-recognized effect of these hormones to inhibit insulin secretion. To determine whether these inhibitory hormones might regulate insulin synthesis at the level of insulin gene transcription, we studied HIT cell expression of a human insulin-chloramphenicol acetyl transferase (CAT) reporter gene in the presence of glucose, epinephrine, and somatostatin. HIT cell expression of this human insulin-CAT reporter gene was responsive to glucose in a concentration-dependent manner, increasing threefold as the glucose concentration increased from 0.4 to 11 mM. Epinephrine significantly inhibited insulin-CAT reporter gene expression (61 ± 5{\%} of control), an effect mediated specifically by the human insulin gene promoter/enhancer sequence. Somatostatin significantly inhibited expression of the human insulin-CAT reporter gene (65 ± 4{\%} of control) and, to a lesser extent, expression of a control reporter gene, pRSVCAT (78 ± 4{\%} of control). Thus, somatostatin may inhibit insulin gene transcription by insulin gene- specific effects as well as more general effects on gene expression. Both epinephrine and somatostatin inhibited expression of the human insulin-CAT reporter gene in a concentration-dependent manner that paralleled inhibition of insulin secretion. These studies indicate that epinephrine and somatostatin lower HIT cell insulin mRNA levels in part by inhibiting insulin gene transcription. Thus, hormonal inhibition of insulin secretion may be coupled with inhibition of insulin synthesis, thereby allowing the β-cell to match insulin supply to secretory demand.",
author = "Redmon, {Bruce B} and Towle, {Howard C.} and Paul Robertson",
year = "1994",
month = "1",
day = "1",
doi = "10.2337/diab.43.4.546",
language = "English (US)",
volume = "43",
pages = "546--551",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "4",

}

TY - JOUR

T1 - Regulation of human insulin gene transcription by glucose, epinephrine, and somatostatin

AU - Redmon, Bruce B

AU - Towle, Howard C.

AU - Robertson, Paul

PY - 1994/1/1

Y1 - 1994/1/1

N2 - We observed in the HIT cell, a clonal insulin-secreting cell line, that epinephrine and somatostatin lower insulin mRNA levels and intracellular insulin content in addition to the well-recognized effect of these hormones to inhibit insulin secretion. To determine whether these inhibitory hormones might regulate insulin synthesis at the level of insulin gene transcription, we studied HIT cell expression of a human insulin-chloramphenicol acetyl transferase (CAT) reporter gene in the presence of glucose, epinephrine, and somatostatin. HIT cell expression of this human insulin-CAT reporter gene was responsive to glucose in a concentration-dependent manner, increasing threefold as the glucose concentration increased from 0.4 to 11 mM. Epinephrine significantly inhibited insulin-CAT reporter gene expression (61 ± 5% of control), an effect mediated specifically by the human insulin gene promoter/enhancer sequence. Somatostatin significantly inhibited expression of the human insulin-CAT reporter gene (65 ± 4% of control) and, to a lesser extent, expression of a control reporter gene, pRSVCAT (78 ± 4% of control). Thus, somatostatin may inhibit insulin gene transcription by insulin gene- specific effects as well as more general effects on gene expression. Both epinephrine and somatostatin inhibited expression of the human insulin-CAT reporter gene in a concentration-dependent manner that paralleled inhibition of insulin secretion. These studies indicate that epinephrine and somatostatin lower HIT cell insulin mRNA levels in part by inhibiting insulin gene transcription. Thus, hormonal inhibition of insulin secretion may be coupled with inhibition of insulin synthesis, thereby allowing the β-cell to match insulin supply to secretory demand.

AB - We observed in the HIT cell, a clonal insulin-secreting cell line, that epinephrine and somatostatin lower insulin mRNA levels and intracellular insulin content in addition to the well-recognized effect of these hormones to inhibit insulin secretion. To determine whether these inhibitory hormones might regulate insulin synthesis at the level of insulin gene transcription, we studied HIT cell expression of a human insulin-chloramphenicol acetyl transferase (CAT) reporter gene in the presence of glucose, epinephrine, and somatostatin. HIT cell expression of this human insulin-CAT reporter gene was responsive to glucose in a concentration-dependent manner, increasing threefold as the glucose concentration increased from 0.4 to 11 mM. Epinephrine significantly inhibited insulin-CAT reporter gene expression (61 ± 5% of control), an effect mediated specifically by the human insulin gene promoter/enhancer sequence. Somatostatin significantly inhibited expression of the human insulin-CAT reporter gene (65 ± 4% of control) and, to a lesser extent, expression of a control reporter gene, pRSVCAT (78 ± 4% of control). Thus, somatostatin may inhibit insulin gene transcription by insulin gene- specific effects as well as more general effects on gene expression. Both epinephrine and somatostatin inhibited expression of the human insulin-CAT reporter gene in a concentration-dependent manner that paralleled inhibition of insulin secretion. These studies indicate that epinephrine and somatostatin lower HIT cell insulin mRNA levels in part by inhibiting insulin gene transcription. Thus, hormonal inhibition of insulin secretion may be coupled with inhibition of insulin synthesis, thereby allowing the β-cell to match insulin supply to secretory demand.

UR - http://www.scopus.com/inward/record.url?scp=0028281774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028281774&partnerID=8YFLogxK

U2 - 10.2337/diab.43.4.546

DO - 10.2337/diab.43.4.546

M3 - Article

VL - 43

SP - 546

EP - 551

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 4

ER -